BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 29951914)

  • 1. The co-occurrence of driver mutations in chronic myeloproliferative neoplasms.
    Boddu P; Chihara D; Masarova L; Pemmaraju N; Patel KP; Verstovsek S
    Ann Hematol; 2018 Nov; 97(11):2071-2080. PubMed ID: 29951914
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic myeloproliferative neoplasms with concomitant
    Zanelli M; Fragliasso V; Loscocco GG; Sanguedolce F; Broggi G; Zizzo M; Palicelli A; Ricci S; Ambrogi E; Martino G; Aversa S; Coppa F; Gentile P; Gozzi F; Caltabiano R; Koufopoulos N; Asaturova A; Cimino L; Cavazza A; Orcioni GF; Ascani S
    Front Cell Dev Biol; 2024; 12():1391078. PubMed ID: 38596359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Co-occurrence of
    Zanelli M; Bisagni A; Sanguedolce F; Broggi G; Fragliasso V; Zizzo M; Palicelli A; Martino G; Cresta C; Caprera C; Corsi M; Gentile P; Gozzi F; Trombetta D; Parente P; Caltabiano R; Koufopoulos N; Cimino L; Cavazza A; Fraternali Orcioni G; Ascani S
    Front Oncol; 2023; 13():1329298. PubMed ID: 38282677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coexisting driver mutations in MPN: clinical and molecular characteristics of a series of 11 patients.
    De Roeck L; Michaux L; Debackere K; Lierman E; Vandenberghe P; Devos T
    Hematology; 2018 Dec; 23(10):785-792. PubMed ID: 29993347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A 68-Year-Old Man with a Cytogenetic Diagnosis of Chronic Myeloid Leukemia and Bone Marrow Findings of Philadelphia Chromosome Translocation Between the Long Arm of Chromosomes 9 and 22, Leading to the BCR-ABL1 Fusion Gene and V617F Mutation in the JAK2 Gene.
    Warsi A; Alamoudi S; Alsuraihi AK; Althobaiti M; Daghistani M; Samarin K; Alahmadi MO; Abuyabis RG; Bogari RA; Filimban SA
    Am J Case Rep; 2023 Mar; 24():e938488. PubMed ID: 36864712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thrombocytosis and STAT5 activation in chronic myelogenous leukaemia are not associated with JAK2 V617F or calreticulin mutations.
    Turakhia SK; Murugesan G; Cotta CV; Theil KS
    J Clin Pathol; 2016 Aug; 69(8):713-9. PubMed ID: 26754830
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful Treatment of a Patient with Chronic Myelogenous Leukemia with Concurrent Janus Kinase 2 (JAK2) R795S Mutation and Breakpoint Cluster Region-ABL1 (BCR-ABL1) Fusion: A Case Report and Literature Review.
    Yue Y; Wei W; Guo Y; Wang F; Dong W; Liu Y; Lin Y; Cao Y; Gu W
    Am J Case Rep; 2020 Oct; 21():e925151. PubMed ID: 33021971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unique Case of Myeloproliferative Neoplasm with Two Rare Clonal Abnormalities: Rare JAK2 Exon 12 Mutation and Rare e14a3 (b3a3) BCR/ABL Fusion Transcript.
    Swaminathan M; Patel KP; Huynh-Lu J; Tang G; Zuo Z; Miranda R; Verstovsek S
    Acta Haematol; 2019; 141(1):23-27. PubMed ID: 30463063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Philadelphia+ Chronic Myeloid Leukemia with CALR Mutation: A Case Report and Literature Review.
    Yoon SY; Jeong SY; Kim C; Lee MY; Kim J; Kim KH; Lee N; Won JH
    Cancer Res Treat; 2020 Jul; 52(3):987-991. PubMed ID: 32019282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical characteristics and whole exome/transcriptome sequencing of coexisting chronic myeloid leukemia and myelofibrosis.
    Kandarpa M; Wu YM; Robinson D; Burke PW; Chinnaiyan AM; Talpaz M
    Am J Hematol; 2017 Jun; 92(6):555-561. PubMed ID: 28335073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dasatinib: a tyrosine kinase inhibitor for the treatment of chronic myelogenous leukemia and philadelphia chromosome-positive acute lymphoblastic leukemia.
    Steinberg M
    Clin Ther; 2007 Nov; 29(11):2289-308. PubMed ID: 18158072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and hematological relevance of JAK2 V617F and CALR mutations in BCR-ABL-negative ET patients.
    Limsuwanachot N; Rerkamnuaychoke B; Chuncharunee S; Pauwilai T; Singdong R; Rujirachaivej P; Chareonsirisuthigul T; Siriboonpiputtana T
    Hematology; 2017 Dec; 22(10):599-606. PubMed ID: 28406068
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of CALR Mutation in Clonal and Nonclonal Hematologic Diseases Using Fragment Analysis and Next-Generation Sequencing.
    Gardner JA; Peterson JD; Turner SA; Soares BL; Lancor CR; Dos Santos LL; Kaur P; Ornstein DL; Tsongalis GJ; de Abreu FB
    Am J Clin Pathol; 2016 Oct; 146(4):448-55. PubMed ID: 27686171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myeloproliferative neoplasms: A decade of discoveries and treatment advances.
    Tefferi A
    Am J Hematol; 2016 Jan; 91(1):50-8. PubMed ID: 26492355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic myeloid leukemia (CML) evolves from Philadelphia chromosome-negative myeloproliferative neoplasms (MPNs) with unexpected frequency.
    Hochman MJ; Smith BD; Karantanos T; Braunstein EM; Gojo I; Jain T; Streiff MB; Moliterno AR; DeZern AE
    Int J Hematol; 2023 Mar; 117(3):456-462. PubMed ID: 36181657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Philadelphia Chromosome Positive Chronic Myelogenous Leukemia Blastic Crisis in A Patient with Unusual Primary Myelofibrosis Characteristics; A Case Report.
    Razmara Lak E; Sharifzadeh S; Ramzi M; Mokhtari M; Asadpouri R; Abedi E; Tamaddon G
    Cardiovasc Hematol Agents Med Chem; 2023 Jun; ():. PubMed ID: 37317905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Two myeloproliferative diseases in one patient - co-occurence of clones].
    Fekete S; Reichardt J; Kozma A; Kapócs K; Meggyesi N
    Orv Hetil; 2022 Jul; 163(28):1123-1129. PubMed ID: 35895464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Atypical myeloproliferative neoplasm with a small population of Philadelphia chromosome-positive clones in the bone marrow].
    Takai K; Ushiki T; Nikkuni K; Hashidate H; Shibuya H
    Rinsho Ketsueki; 2011 Feb; 52(2):73-7. PubMed ID: 21403427
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Co-occurrence of BCR-ABL1-positive chronic myeloid leukaemia and CALR-mutated essential thrombocythaemia.
    da Costa VEF; de Oliveira RD; Traina F; Chahud F; Palma LC; de Figueiredo-Pontes LL
    Br J Haematol; 2020 Feb; 188(3):e21-e23. PubMed ID: 31681999
    [No Abstract]   [Full Text] [Related]  

  • 20. Discovery of the Philadelphia chromosome: a personal perspective.
    Nowell PC
    J Clin Invest; 2007 Aug; 117(8):2033-5. PubMed ID: 17671636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.